Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis.
Sasaki Y, Hamaguchi T, Yamada Y, Takahashi N, Shoji H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Nagai Y, Taniguchi H, Boku N, Ushijima T, Shimada Y.
Sasaki Y, et al. Among authors: takashima a.
Asian Pac J Cancer Prev. 2016;17(2):539-43. doi: 10.7314/apjcp.2016.17.2.539.
Asian Pac J Cancer Prev. 2016.
PMID: 26925640
Free article.